A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after MoonLake announced disastrous Phase 3 trial results for its only ...
Electricity powers our lives, including our cars, phones, computers, and more, through the movement of electrons within a ...
Teachers and parents packed the Whitman-Hanson High School auditorium on Wednesday night, demanding answers after learning ...
On October 31, 2025, Anika submitted the third and final module of its Hyalofast PMA to the U.S. Food and Drug Administration (FDA). The PMA includes FastTRACK 24-month data and incorporates ...
Mean weight loss of 19.2%I at 6 mg with no plateau and favorable safety profile in 48-week Phase 3 clinical trial –– Data builds on previously ...
Abstract: As the demand for energy in AI-driven data centers continues to rise, there is an urgent need for innovative solutions to enhance the efficiency and power density of isolated three-phase ...
Investigational gefurulimab met its primary efficacy endpoint in adults with anti-acetylcholine receptor (AChR) ...
Abstract: As doubly fed induction generator(DFIG) has special control and low voltage ride-through strategy, which leads to the traditional industrial frequency ...
AI’s engine rooms are spreading to rural counties. The question isn’t whether to build them, but how to make them serve communities and regions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback